Is CTCX or JEPQ a better dividend investment in 2026?

CTCX currently yields 1013.68% with a 5% 5-year dividend growth rate. JEPQ yields 11.10% with 5% growth. The better choice depends on your goal: CTCX offers higher current income.

What is the dividend yield difference between CTCX and JEPQ?

CTCX has a forward dividend yield of 1013.68% ($2.00/share annually). JEPQ yields 11.10% ($6.16/share annually). The yield gap is 1002.58 percentage points.

Home › Compare › CTCX vs JEPQ

CTCX vs JEPQ: Dividend Comparison 2026

CTCX yields 1013.68% · JEPQ yields 11.10%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CTCX wins by $21217097.08M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CTCX

● Live price

1013.68%

Share price

$0.20

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$21217097.13M

Annual income

$17,768,877,895,719.51

Full CTCX calculator →

JEPQ

JPMorgan Nasdaq Equity Premium Income ETF

● Live price

11.10%

Share price

$55.52

Annual div

$6.16

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.8K

Annual income

$2,152.59

Full JEPQ calculator →

Portfolio growth — CTCX vs JEPQ

📍 CTCX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CTCX	JEPQ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CTCX + JEPQ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CTCX pays

JEPQ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CTCX

Annual income on $10K today (after 15% tax)

$86,163.20/yr

After 10yr DRIP, annual income (after tax)

$15,103,546,211,361.58/yr

JEPQ

Annual income on $10K today (after 15% tax)

$943.83/yr

After 10yr DRIP, annual income (after tax)

$1,829.70/yr

At 15% tax rate, CTCX beats the other by $15,103,546,209,531.88/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CTCX + JEPQ for your $10,000?

CTCX: 50%JEPQ: 50%

100% JEPQ50/50100% CTCX

Portfolio after 10yr

$10608548.58M

Annual income

$8,884,438,948,936.04/yr

Blended yield

83.75%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CTCX buys

JEPQ buys

No recent congressional trades found for CTCX or JEPQ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCTCXJEPQ

Forward yield	1013.68% ✓	11.10%
Annual dividend / share	$2.00	$6.16 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$21217097.13M ✓	$44.8K
Annual income after 10y	$17,768,877,895,719.51 ✓	$2,152.59
Total dividends collected	$20954125.95M ✓	$16.3K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: CTCX vs JEPQ ($10,000, DRIP)

Year	CTCX Portfolio	CTCX Income/yr	JEPQ Portfolio	JEPQ Income/yr	Gap
1← crossover	$112,068	$101,368.47	$11,930	$1,110.39	+$100.1K → CTCX
2	$1,181,615	$1,061,701.90	$14,133	$1,224.34	+$1.17M → CTCX
3	$11,726,249	$10,461,920.38	$16,632	$1,340.46	+$11.71M → CTCX
4	$109,578,123	$97,031,037.37	$19,454	$1,457.97	+$109.56M → CTCX
5	$964,654,833	$847,406,240.94	$22,626	$1,576.08	+$964.63M → CTCX
6	$8,004,158,004	$6,971,977,332.68	$26,175	$1,694.09	+$8004.13M → CTCX
7	$62,629,410,485	$54,064,961,420.43	$30,133	$1,811.32	+$62629.38M → CTCX
8	$462,375,346,702	$395,361,877,482.99	$34,531	$1,927.17	+$462375.31M → CTCX
9	$3,222,634,793,872	$2,727,893,172,901.40	$39,403	$2,041.08	+$3222634.75M → CTCX
10	$21,217,097,125,163	$17,768,877,895,719.51	$44,787	$2,152.59	+$21217097.08M → CTCX

CTCX vs JEPQ: Complete Analysis 2026

CTCX — Stock

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.

Full CTCX Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →

📬

Get this CTCX vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CTCX vs SCHD CTCX vs JEPI CTCX vs O CTCX vs KO CTCX vs MAIN CTCX vs XYLD CTCX vs QYLD CTCX vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.